Philip D Greenberg
Affiliations: | Immunology | University of Washington, Seattle, Seattle, WA |
Google:
"Philip Greenberg"Children
Sign in to add trainee| Rosalynde J. Finch | grad student | 2000 | University of Washington |
| Laurence E. Cheng | grad student | 2002 | University of Washington |
| Michelle L. Dossett | grad student | 2006 | University of Washington |
| Carla C. Fowler | grad student | 2010 | University of Washington |
| Cassie K. Chou | grad student | 2012 | University of Washington |
| Ingunn M. Stromnes | post-doc | University of Washington (Neurotree) | |
| Yapeng Su | post-doc | (Chemistry Tree) | |
| Joseph N. Blattman | post-doc | 2001-2011 | University of Washington |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Martinov T, Greenberg PD. (2023) Targeting Driver Oncogenes and Other Public Neoantigens Using T Cell Receptor-Based Cellular Therapy. Annual Review of Cancer Biology. 7: 331-351 |
| Chour W, Choi J, Xie J, et al. (2023) Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysis. Communications Biology. 6: 528 |
| Nava Lauson CB, Tiberti S, Corsetto PA, et al. (2023) Linoleic acid potentiates CD8 T cell metabolic fitness and antitumor immunity. Cell Metabolism |
| Heath J, Chour W, Choi J, et al. (2022) Large libraries of single-chain trimer peptide-MHCs enable rapid antigen-specific CD8+ T cell discovery and analysis. Research Square |
| Anderson KG, Oda SK, Bates BM, et al. (2022) Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy. Journal For Immunotherapy of Cancer. 10 |
| Su Y, Yuan D, Chen DG, et al. (2022) Multiple early factors anticipate post-acute COVID-19 sequelae. Cell |
| Stromnes IM, Hulbert A, Rollins MR, et al. (2022) Insufficiency of compound immune checkpoint blockade to overcome engineered T cell exhaustion in pancreatic cancer. Journal For Immunotherapy of Cancer. 10 |
| Lahman MC, Schmitt TM, Paulson KG, et al. (2022) Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency. Science Translational Medicine. 14: eabg8070 |
| Lee JW, Su Y, Baloni P, et al. (2021) Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19. Nature Biotechnology |
| Su Y, Chen D, Yuan D, et al. (2020) Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19. Cell |